• bitcoinBitcoin(BTC)$63,523.00-1.33%
  • ethereumEthereum(ETH)$1,797.73-0.25%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$586.69-0.80%
  • usd-coinUSDC(USDC)$1.000.01%
  • rippleXRP(XRP)$0.97-0.37%
  • solanaSolana(SOL)$74.51-0.51%
  • tronTRON(TRX)$0.3113861.13%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.021.59%
  • HyperliquidHyperliquid(HYPE)$67.72-1.12%
  • zcashZcash(ZEC)$932.24-2.22%
  • moneroMonero(XMR)$502.30-0.26%
  • dogecoinDogecoin(DOGE)$0.0591900.04%
  • leo-tokenLEO Token(LEO)$9.30-0.47%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$61.62-0.84%
  • chainlinkChainlink(LINK)$9.14-0.62%
  • cardanoCardano(ADA)$0.152804-0.17%
  • stellarStellar(XLM)$0.137168-2.09%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • nearNEAR Protocol(NEAR)$3.401.14%
  • daiDai(DAI)$1.000.00%
  • bitcoin-cashBitcoin Cash(BCH)$206.87-0.71%
  • litecoinLitecoin(LTC)$44.500.22%
  • CantonCanton(CC)$0.083299-0.01%
  • RainRain(RAIN)$0.004649-1.55%
  • uniswapUniswap(UNI)$5.21-0.07%
  • avalanche-2Avalanche(AVAX)$7.08-0.70%
  • tether-goldTether Gold(XAUT)$3,716.12-1.52%
  • suiSui(SUI)$0.72-0.22%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.03-4.46%
  • USD1USD1(USD1)$1.000.00%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.055929-2.29%
  • paypal-usdPayPal USD(PYUSD)$1.000.02%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.05%
  • BittensorBittensor(TAO)$195.140.07%
  • shiba-inuShiba Inu(SHIB)$0.000004-0.06%
  • crypto-com-chainCronos(CRO)$0.042554-1.79%
  • quant-networkQuant(QNT)$149.63-2.07%
  • MemeCoreMemeCore(M)$0.90-1.25%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.21%
  • okbOKB(OKB)$87.460.71%
  • aaveAave(AAVE)$109.38-1.85%
  • Falcon USDFalcon USD(USDF)$1.00-0.02%
  • pax-goldPAX Gold(PAXG)$3,716.01-1.62%
  • United StablesUnited Stables(U)$1.000.01%
  • pepePepe(PEPE)$0.0000040.80%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Pharmaceutical Company Merck Offers Free License for HIV Drug for Young Children

July 28, 2023
in Trade Tube
Reading Time: 2 mins read
A A
ShareShareShareShareShare



Drugmaker Merck has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus. The deal, announced Tuesday, lets any generic or brand name drug manufacturer make low-cost pediatric versions of Merck’s raltegravir for sale in 92 low- and middle-income countries, according to the Medicines Patent Pool. The group, backed by the United Nations, works with brand-name drugmakers to find ways to make their HIV medicines still covered by patents available in developing countries for a fraction of the price charged in Europe or the United States. Merck, based in Kenilworth, New Jersey, sells raltegravir under the brand name Isentress. In the U.S., it costs about $1,350 a month without insurance. The patent pool is now starting to line up manufacturers to produce raltegravir for poor countries, where the patent runs until about 2022. Based on prior licensing deals made by the group, the pills could be priced between 47 percent and 87 percent less than Isentress now costs. According to the Geneva-based organization, about 98 percent of children with HIV live in India, South Africa and other developing countries. That’s because unlike in wealthier countries, their mothers aren’t likely during their pregnancy to be tested for HIV and given medicines to prevent transmitting the virus during childbirth. ‘Without antiretroviral therapy, 50 percent of infants living with HIV/AIDS will die by the age of 2, and 80 percent by the age of 5,’ Dr. Deborah Birx, U.S. global AIDS coordinator, said in a statement.

Subscribe to TheStreetTV on YouTube:

YOU MAY ALSO LIKE

Start protecting the life you’re building with LifeLock.

The Reason No One Can Catch NVIDIA

For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:

source

ShareTweetSendSharePin

Related Posts

Start protecting the life you’re building with LifeLock.
Trade Tube

Start protecting the life you’re building with LifeLock.

November 19, 2026
The Reason No One Can Catch NVIDIA
Trade Tube

The Reason No One Can Catch NVIDIA

November 19, 2026
Insane AI Breakthroughs Nobody Is Talking About
Trade Tube

Insane AI Breakthroughs Nobody Is Talking About

November 19, 2026
MiniMax H3 Image – Normal + GGUF Guide!
Trade Tube

MiniMax H3 Image – Normal + GGUF Guide!

November 18, 2026
Next Post
Plans to Build an NFL Stadium in the LA Area Goes Up for Vote by Inglewood City Council

Plans to Build an NFL Stadium in the LA Area Goes Up for Vote by Inglewood City Council

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Man jumps into school bus after driver has medical issue

Man jumps into school bus after driver has medical issue

November 18, 2026
A Latte Every Workday Costs Over ,000 a Year – Brew Most Cups at Home

A Latte Every Workday Costs Over $1,000 a Year – Brew Most Cups at Home

November 12, 2026
Widespread protests expand across Europe as thousands take to streets

Widespread protests expand across Europe as thousands take to streets

November 17, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!